According to Zhitong Finance APP, AMASSE CAPITAL (08168) on December 16, 2024 (after trading hours), the company has entered into a memorandum of understanding with Ting Chuang (Tancheng) Biotechnology, under which the parties agree to sincerely negotiate to establish a formal agreement for possible cooperation, which includes but is not limited to Business cooperation and product promotion, strategic investment, establishment of a joint venture, and/or provision of financing.

It is reported that Ting Chuang (Tancheng) Biotechnology mainly engages in the research and development, production, and sale of probiotic products in China.

Directors believe that potential cooperation may provide the group with opportunities to explore diverse revenue sources or offer strategic opportunities for additional income.